Elotuzumab

CHEBI:CHEBI_752732

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Elotuzumab
rxcui
1726119
pharm_class
SLAMF7-directed Antibody Interactions [MoA]
product_type
BULK INGREDIENT
listing_expiration_date
20241231
active_ingredient_strength
1 kg/kg
route
INTRAVENOUS
dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
marketing_category
BULK INGREDIENT
marketing_start_date
20151130
nui
N0000192337
pharm_class_cs
Antibodies, Monoclonal [CS]
package_marketing_start_date
08-MAR-24
labeler_name
Lotte Biologics USA, LLC
manufacturer_name
E.R. Squibb & Sons, L.L.C.
product_ndc
0003-2291
spl_id
1549f88a-35c1-9894-e063-6294a90a6698
active_ingredient_name
ELOTUZUMAB
package_ndc
0003-2291-11
package_description
1 VIAL, SINGLE-USE in 1 CARTON (0003-2291-11) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE
brand_name
EMPLICITI
brand_name_base
EMPLICITI
application_number
BLA761035
unii
1351PE5UGS
spl_set_id
80686b7e-f6f4-4154-b5c0-c846425e2d91
upc
0300032291118
pharm_class_epc
SLAMF7-directed Immunostimulatory Antibody [EPC]
pharm_class_moa
SLAMF7-directed Antibody Interactions [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class